Position in XENE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$15,274,493
+$9,273,902 QoQ
Shares Held
262,674
+96.2% QoQ
Ownership
0.272%
of shares outstanding
% of Portfolio
1.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Redmile Group, LLC holds $1,432,283,191 across 31 Biotechnology names. XENE ranks #16 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SRRK |
Scholar Rock Holding Corp
|
9,066,621 | $445,715,088 | |
| 2 | KRYS |
Krystal Biotech, Inc.
|
673,505 | $173,979,811 | |
| 3 | STOK |
Stoke Therapeutics, Inc.
|
4,164,120 | $135,583,747 | |
| 4 | IMNM |
Immunome Inc.
|
5,558,885 | $121,572,814 | |
| 5 | NRIX |
Nurix Therapeutics, Inc.
|
7,732,808 | $119,858,524 | |
| 6 | ANNX |
Annexon, Inc.
|
14,549,768 | $80,605,714 | |
| 7 | RGNX |
REGENXBIO Inc.
|
4,368,804 | $36,610,577 | |
| 8 | STTK |
Shattuck Labs, Inc.
|
5,539,724 | $35,620,425 |
All Filings in XENE
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,274,493 | 262,674 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,000,591 | 133,882 | Shares | Sole | 2026-02-17 | |
| 2023-09-30 | $14,332,442 | 419,568 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $43,138,326 | 1,120,476 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $47,451,527 | 1,325,832 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $93,071,124 | 2,360,414 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $85,579,165 | 2,370,614 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $49,868,844 | 1,639,344 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||